7 Highest Yielding Dividend Aristocrats Like AbbVie Are The Best 2024 Ideas Now24/7 Wall Street • 01/21/24
Enigma Biomedical Group - USA Signs License Agreement with AbbVie for Novel 4R Tau PET Imaging BiomarkersBusiness Wire • 01/18/24
Here's the Average Amount Investors Have in Stocks by Age 40 and Which Stocks I Recommend TodayThe Motley Fool • 01/14/24
2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a DecadeThe Motley Fool • 01/11/24
My Dividend Stock Portfolio: New December Dividend Record - 98 Holdings With 18 BuysSeeking Alpha • 01/10/24
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European UnionPRNewsWire • 01/09/24
Lutikizumab Showed Positive Results in a Phase 2 Trial of Adults with Moderate to Severe Hidradenitis Suppurativa as Program Advances to Phase 3PRNewsWire • 01/08/24